The therapeutic management of children with sickle cell disease primarily consists of which of the following?

• A. Oxygen therapy
• B. Adequate hydration
• C. Prevention and treatment of pain
• D. Frequent blood transfusions

Answer: (D)

The main goal in pediatric sickle cell disease management is to prevent and treat painful vaso-occlusive crises. Controlling pain promptly and effectively reduces hospitalizations, improves quality of life, and lowers long-term morbidity, making pain management the most consistent and central aspect of therapy. Hydration supports this care and helps lessen blood viscosity, but it does not by itself address the frequency and severity of painful crises. Oxygen therapy is not routinely needed unless there is hypoxemia or a lung complication. Frequent blood transfusions have important roles for specific situations (such as acute severe anemia, stroke prevention in high-risk patients, or acute chest syndrome) but they carry risks like iron overload and alloimmunization and are not the general primary approach for all children. Thus, preventing and treating pain best reflects the core therapeutic objective in most pediatric cases.